Lyme Disease Vaccine May Reach Market Within Five Years

10 hours ago ... Boomers are skipping needed vaccines · Explore the full list of benefits available to you as an AARP Member · Should you record your next ...
Source: AARP.org News - Category: American Health Source Type: news

Related Links:

Authors: BrodziƄski S, Nasierowski T Abstract In the second part of the article case reports of three patients were presented. All patientswere treated for Borrelia infection and all of them developed psychotic disorders. History of each patient was different, as well as the probability of causal relationship between neuroborreliosis and psychosis. The first case concerns a female patient with no former psychiatric history, who developed psychotic episode secondary to neuroborreliosis. Psychotic disorders resolved after antibiotic treatment. In the second case, a male patient was previously twice hospitalized in p...
Source: Psychiatria Polska - Category: Psychiatry Tags: Psychiatr Pol Source Type: research
Listen: Mayo Clinic Radio 8/10/19 On the Mayo Clinic Radio podcast, Dr. Gregory Poland, a Mayo Clinic infectious diseases and vaccine expert, gives an update on infectious disease hot topics, including Lyme disease, the ongoing concern about measles, the hope for a universal flu vaccine and new age guidelines for the HPV vaccine. Also on the podcast, Dr. John Lieske explains how kidney stones form and how [...]
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news
New cases of tick-borne Lyme disease might top 8000 in 2019, researchers estimate Related items fromOnMedica Well over half of people have never had an STI test HPV programme linked to dramatic fall in cervical disease Should we have compulsory measles vaccination at school entry? Promise to end new HIV transmissions in England by 2030 Decision to give boys HPV jab will save thousands of lives
Source: OnMedica Latest News - Category: UK Health Source Type: news
Publication date: Available online 29 July 2019Source: Ticks and Tick-borne DiseasesAuthor(s): Sara Niesobecki, AmberJean Hansen, Heather Rutz, Shaylee Mehta, Katherine Feldman, James Meek, Linda Niccolai, Sarah Hook, Alison HinckleyAbstractAs part of a TickNET collaboration we evaluated the knowledge, attitudes, and behaviors related to tick-borne disease (TBD) prevention among persons living in endemic areas of Connecticut (CT) and Maryland (MD). Up-to-date information on the use of various prevention methods, as well as attitudes toward available and potential prevention options, is critical for effective promotion of r...
Source: Ticks and Tick borne Diseases - Category: Zoology Source Type: research
Discussion Dengue is an important arboviral infection that affects about 40% of the world population. It is found mainly in topical and subtropical areas of the world mainly in developing countries but it range is spreading including the United States. A review of common arboviruses can be found here. It is a flaviavirus with 4 distinct serotypes named DENV-1 through DENV-4 and is spread by A. aegypti a day biting mosquito. Infection with one serotype confers immunity to that serotype but not the others. It does offer some protection for cross-infection but this only lasts a few months. Incubation period is 3-14 days with ...
Source: PediatricEducation.org - Category: Pediatrics Authors: Tags: Uncategorized Source Type: news
Health officials have confirmed that an individual in Maine is sick with Powassan virus disease, marking the first time since 2017 that a person in the state has come down with the rare and serious tick-borne illness. The Maine Center for Disease Control and Prevention announced Wednesday that a southern Maine resident was hospitalized for Powassan encephalitis—brain inflammation associated with the virus—after showing symptoms in late June. The announcement did not specify the individual’s current condition, but health officils doctors to stay vigilant about the potential spread of Powassan throughout th...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Maine onetime Source Type: news
This study is significant because it now allows us to systematically test the putative epitopes for their protective efficacy with an ultimate goal of selecting the most efficacious targets for development of a long-awaited LD vaccine.
Source: Infection and Immunity - Category: Infectious Diseases Authors: Tags: Microbial Immunity and Vaccines Source Type: research
Lab tests not needed if rash is present, says NICE Related items fromOnMedica TB could be cured by four months ’ treatment in many patients Antibiotics courses often longer than guidelines Doctors call for StrepB screening in late pregnancy JCVI recommends universal HPV vaccination New ‘treadmill test’ can predict mortality
Source: OnMedica Latest News - Category: UK Health Source Type: news
Borrelia burgdorferi is a tick-borne bacterium responsible for approximately 300,000 annual cases of Lyme disease (LD) in the United States, with increasing incidences in other parts of the world. The debilitating nature of LD is mainly attributed to the ability of B. burgdorferi to persist in patients for many years despite strong anti-Borrelia antibody responses. Antimicrobial treatment of persistent infection is challenging. Similar to infection of humans, B. burgdorferi establishes long-term infection in various experimental animal models except for New Zealand White (NZW) rabbits, which clear the spirochete within 4 t...
Source: Infection and Immunity - Category: Infectious Diseases Authors: Tags: Cellular Microbiology: Pathogen-Host Cell Molecular Interactions Source Type: research
Condition:   Lyme Borreliosis Interventions:   Biological: VLA15;   Biological: Placebo Sponsor:   Valneva Austria GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: American Health | Lyme Disease | Vaccines